Salvatore Florio

Prof. Dr. Salvatore Florio

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
SDSara Damiano
Sara Damiano
Consiglia LongobardiConsiglia Longobardi
Consiglia Longobardi
EAEmanuela Andretta
Emanuela Andretta
FPFrancesco Prisco
Francesco Prisco
Giuseppe PiegariGiuseppe Piegari
Giuseppe Piegari
RCRoberto Ciarcia
Roberto Ciarcia
Ochratoxin A (OTA) is a powerful mycotoxin found in various foods and feedstuff, responsible for subchronic and chronic toxicity, such as nephrotoxicity, hepatotoxicity, teratogenicity, and immunotoxicity to both humans and several animal species. The severity of the liver damage caused depends on both dose and duration of exposure. Several studies have suggested that oxidative stress might contribute to increasing the hepatotoxicity of OTA, and several antioxidants, including curcumin (CURC), have been tested to counteract the toxic hepatic action of OTA in various classes of animals. Therefore, the present study was designed to evaluate the protective effect of CURC, a bioactive compound with different therapeutic properties on hepatic injuries caused by OTA in rat animal models. CURC effects were examined in Sprague Dawley rats treated with CURC (100 mg/kg), alone or in combination with OTA (0.5 mg/kg), by gavage daily for 14 days. At the end of the experiment, rats treated with OTA showed alterations in biochemical parameters and oxidative stress in the liver. CURC dosing significantly attenuated oxidative stress and lipid peroxidation versus the OTA group. Furthermore, liver histological tests showed that CURC reduced the multifocal lymphoplasmacellular hepatitis, the periportal fibrosis, and the necrosis observed in the OTA group. This study provides evidence that CURC can preserve OTA-induced oxidative damage in the liver of rats.

18 April 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
SDSara Damiano
Sara Damiano
EAEmanuela Andretta
Emanuela Andretta
Consiglia LongobardiConsiglia Longobardi
Consiglia Longobardi
FPFrancesco Prisco
Francesco Prisco
Orlando PacielloOrlando Paciello
Orlando Paciello
RCRoberto Ciarcia
Roberto Ciarcia
Ochratoxin A (OTA) is a powerful nephrotoxin and the severity of its damage to kidneys depends on both the dose and duration of exposure. According to the scientific data currently available, the mechanism of action still is not completely clarified, but it is supposed that oxidative stress is responsible for OTA-induced nephrotoxicity. Bioactive compound use has emerged as a potential approach to reduce chronic renal failure. Therefore, curcumin (CURC), due to its therapeutic effects, has been chosen for our study to reduce the toxic renal effects induced by OTA. CURC effects are examined in Sprague Dawley rats treated with CURC (100 mg/kg), alone or in combination with OTA (0.5 mg/kg), by gavage daily for 14 days. The end result of the experiment finds rats treated with OTA show alterations in biochemical and oxidative stress parameters in the kidney, related to a decrease in the Glomerular Filtration Rate (GFR). Conversely, the administration of CURC attenuates oxidative stress and prevents glomerular hyperfiltration versus the OTA group. Furthermore, kidney histological tests show a reduction in glomerular and tubular damage, inflammation and tubulointerstitial fibrosis. This study shows that CURC can mitigate OTA–induced oxidative damage in the kidneys of rats.

2 August 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Consiglia LongobardiConsiglia Longobardi
Consiglia Longobardi
SDSara Damiano
Sara Damiano
EAEmanuela Andretta
Emanuela Andretta
FPFrancesco Prisco
Francesco Prisco
VRValeria Russo
Valeria Russo
RCRoberto Ciarcia
Roberto Ciarcia
Ochratoxin A (OTA) is a fungal toxin of critical concern for food safety both for human health and several animal species, also representing a cancer threat to humans. Curcumin (CURC) is a natural polyphenol that has anti-apoptotic, anti-inflammatory, and antioxidant effects. The aim of this study was to investigate the cytoprotective effect of CURC against OTA-induced nephrotoxicity and hepatotoxicity through the study of the nitrosative stress, pro-inflammatory cytokines, and deoxyribonucleic acid (DNA) damage. Sprague Dawley rats were daily treated with CURC (100 mg/kg b.w.), OTA (0.5 mg/kg b.w), or CURC with OTA by oral gavage for 14 days. Our results demonstrated that OTA exposure was associated with significant increase of pro-inflammatory and DNA oxidative-damage biomarkers. Moreover, OTA induced the inducible nitric oxide synthase, (iNOS) resulting in increased nitric oxide (NO) levels both in kidney and liver. The co-treatment OTA + CURC counteracted the harmful effects of chronic OTA treatment by regulating inflammation, reducing NO levels and oxidative DNA damage in kidney and liver tissues. Histology revealed that OTA + CURC treatment determinates mainly an Iba1+ macrophagic infiltration with fewer CD3+ T-lymphocytes in the tissues. In conclusion, we evidenced that CURC exerted cytoprotective and antioxidant activities against OTA-induced toxicity in rats.

22 May 2010 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
RCRoberto Ciarcia
Roberto Ciarcia
DDDanila D'ANgelo
Danila D'ANgelo
CPCarmen Pacilio
Carmen Pacilio
DPDavid Pagnini
David Pagnini
Massimiliano GaldieroMassimiliano Galdiero
Massimiliano Galdiero
Antonio GiordanoAntonio Giordano
Antonio Giordano

1 September 2013 in Cell Cycle
Verified
Journal Article
Open access
PDF file
RCRoberto Ciarcia
Roberto Ciarcia
SDSara Damiano
Sara Damiano
SMSerena Montagnaro
Serena Montagnaro
UPUgo Pagnini
Ugo Pagnini
ARAntonio Ruocco
Antonio Ruocco
Antonio GiordanoAntonio Giordano
Antonio Giordano
Imatinib induces a complete cytogenetic regression in a large percentage of patients affected by chronic myeloid leukemia (CML) until mutations in the kinase domain of BCR-ABL appear. Alternative strategies for CML patients include the inhibition of phosphatidylinositol 3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) pathway, which is constitutively activated in leukemia cells and seems important for the regulation of cell proliferation, viability, and autophagy. In this study, we verified the effect of imatinib mesylate (IM), alone or in association with LY294002 (LY) (a specific PI3K protein tyrosine kinase inhibitor) or 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]-pyrimidine (PP1) (a Src tyrosine kinase inhibitor), on viability, intracellular calcium mobilization, apoptosis, and autophagy, in order to verify possible mechanisms of interaction. Our data demonstrated that PP1 and LY interact synergistically with IM by inducing apoptosis and autophagy in Bcr/Abl+ leukemia cells and this mechanism is related to the stress of the endoplasmic reticulum (ER). Our findings suggest a reasonable relationship between apoptotic and autophagic activity of tyrosine kinase inhibitors (TKIs) and the functionality of smooth ER Ca2+-ATPase and inositol triphosphate receptors, independently of intracellular calcium levels. Therapeutic strategies combining imatinib with PI3K and/or Src kinase inhibitors warrant further investigations in Bcr/Abl+ malignancies, particularly in the cases of imatinib mesylate-resistant disease.

3 February 2003 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SFSalvatore Florio
Salvatore Florio
RCRoberto Ciarcia
Roberto Ciarcia
LCLuca Crispino
Luca Crispino
UPUgo Pagnini
Ugo Pagnini
ARAntonio Ruocco
Antonio Ruocco
FRFerdinando Russo
Ferdinando Russo